Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by James Hardie Industries N.V. (James Hardie) for the month of November 2007, dated November 29, 2007. The registrant is headquartered in Amsterdam, The Netherlands, and files annual reports on Form 20-F. This filing serves to disseminate specific corporate announcements made to the Australian Stock Exchange.
Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing referencing external exhibits rather than a financial results report.
Material Changes
No material financial changes are detailed in the text of this filing. The document focuses on the disclosure of two specific events occurring on November 28, 2007:
- Submission of a daily share buy-back notice (Appendix 3E) to the Australian Stock Exchange.
- Submission of a statement regarding false claims made against James Hardie to the Australian Stock Exchange.
Guidance, Outlook, Risks, and Contingencies
The filing includes a comprehensive Safe Harbor Statement regarding forward-looking statements. Management highlights the following key risks and contingencies that could cause actual results to differ materially from expectations:
- Asbestos Liabilities: Expectations regarding the timing and amount of payments to the Asbestos Injuries Compensation Fund (AICF) and the impact of foreign exchange on asbestos provisions.
- Legal Proceedings: Potential consequences of proceedings brought by the Australian Securities & Investments Commission against the company and former directors/officers.
- Operational Risks: Competition, product pricing, raw material costs, product failures, and environmental liabilities.
- Financial Risks: Extension or renewal of credit facilities and foreign exchange risks.
Key Facts for Investor Verification
- Verify the details of the share buy-back program referenced in Exhibit 99.1 filed with the Australian Stock Exchange on November 28, 2007.
- Review the specific nature of the false claims against the company detailed in Exhibit 99.2.
- Monitor ongoing developments regarding the Asbestos Injuries Compensation Fund (AICF) and related legal proceedings, as these are cited as primary risks.
- Note that this filing contains no new financial performance data; investors should refer to the most recent Form 20-F for financial metrics.